Details for New Drug Application (NDA): 213041
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 213041
Tradename: | SILDENAFIL CITRATE |
Applicant: | Aptapharma Inc |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 213041
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Aug 6, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription